| 期刊全稱 | Alzheimer‘s Disease and the Eye | | 影響因子2023 | Jeffrey N. Weiss | | 視頻video | http://file.papertrans.cn/168/167403/167403.mp4 | | 發(fā)行地址 | Offers a comprehensive review of clinical trials in the field of Alzheimer‘s disease that uses the eye as a biomarker.The first book to provide coverage clinical trials in the field of Alzheimer‘s dis | | 圖書封面 |  | | 影響因子 | .This book is a compendium of the worldwide studies of Alzheimer’s disease utilizing the eye as a biomarker, or as a treatment method, that are registered with the United States National Institutes of Health website, clinicaltrials.gov. Clinicaltrials.gov is the largest listing of research studies in the world. The study titles are provided, as is the country of origin and the Clinical Trial Number in order to make it easier for the reader to locate the study and obtain further information...New drug development is costly and time consuming. If through the use of biomarkers, study durations and research costs decrease, there is a greater possibility of a new and effective drug to treat this devastating disease. The eye offers the possibility of early diagnosis and of treatment...Alzheimer’s Disease and the Eye. is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers...?..?. | | Pindex | Book 2024 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-23 00:04
發(fā)表于 2025-3-21 16:29:20
